5. Results of Clinical Trials Can Be Explained by APP-Independent and BACE Inhibition-Insensitive Generation of Beta Amyloid in Sporadic Alzheimer’s Disease. The gene discussed is BACE1; the disease is early-onset autosomal dominant Alzheimer disease.